GRACE CONSULTING SERVICES INC. FDA Approval ANDA 213698

ANDA 213698

GRACE CONSULTING SERVICES INC.

FDA Drug Application

Application #213698

Documents

Letter2021-10-08

Application Sponsors

ANDA 213698GRACE CONSULTING SERVICES INC.

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2021-09-15STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

GRACE CONSULTING SERVICES INC.
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213698
            [companyName] => GRACE CONSULTING SERVICES INC.
            [docInserts] => ["",""]
            [products] => [{"drugName":"GLYCOPYRROLATE","activeIngredients":"GLYCOPYRROLATE","strength":"1MG\/5ML","dosageForm":"LIQUID;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/15\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/213698Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-09-15
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.